Results 201 to 210 of about 451,760 (295)

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

open access: yesBlood, 2022
Olsen EA   +34 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Ulceronecrotic Plaques, Patchy Scalp Alopecia and Visual Disturbance in a 46‐Year‐Old Man

open access: yesInternational Journal of Dermatology, Volume 65, Issue 12, Page 2460-2462, December 2026.
ABSTRACT A 46‐year‐old incarcerated man with chronic hepatitis C infection and intravenous drug use presented with a rapidly progressive pruritic eruption involving the scalp, trunk, and limbs, accompanied by patchy scalp alopecia and bilateral panuveitis.
Alex Majri   +3 more
wiley   +1 more source

Copy‐Number Alterations in Central Nervous System Tumours: Diagnostic and Prognostic Implications

open access: yesNeuropathology and Applied Neurobiology, Volume 52, Issue 6, December 2026.
This review summarises recurrent copy‐number alterations across the spectrum of CNS tumours, classifies them into diagnostic, prognostic and supportive categories, and highlights how characteristic CNA combinations support tumour classification, grading and risk stratification in neuropathological diagnostics.
Christian Thomas
wiley   +1 more source

Independent evolution of cutaneous lymphoma subclones in different microenvironments of the skin. [PDF]

open access: yesSci Rep, 2020
Iyer A   +6 more
europepmc   +1 more source

Toxicity of Cytarabine Intravenous Constant Rate Infusion in Cats With Lymphoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 4, Page 830-840, December 2026.
ABSTRACT Cytarabine intravenous constant rate infusion (IV CRI) toxicity in cats with lymphoma has not been well documented. We aimed to assess toxicities following cytarabine IV CRI as a single‐agent or within a multiagent protocol in cats with lymphoma. Medical records of cats with lymphoma treated with cytarabine IV CRI, with documented dose, route,
Rachel Hanford   +5 more
wiley   +1 more source

What Is Your Diagnosis? Lymph Node Aspirate From a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
William Benedict   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy